Abstract
The impact of the revised Clinical and Laboratory Standards Institute interpretative criteria for cefepime in Enterobacteriaceae remains unclear. We applied the new breakpoint on 644 previously defined cefepime-susceptible Enterobacteriaceae isolates. We found no differences in mortality or microbiological failure, regardless of isolates being susceptible or cefepime-susceptible dose-dependent by current criteria.
Original language | English |
---|---|
Article number | ofz341 |
Journal | Open Forum Infectious Diseases |
Volume | 6 |
Issue number | 8 |
DOIs | |
State | Published - Aug 1 2019 |
Keywords
- CLSI
- Enterobacteriaceae
- bacteremia
- cefepime
- cefepime-susceptible dose-dependent
- susceptibility